SEPSIS ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)

Clinical trials for SEPSIS ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION (DIC) explained in plain language.

Never miss a new study

Get alerted when new SEPSIS ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION (DIC) trials appear

Sign up with your email to follow new studies for SEPSIS ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION (DIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human test for new sepsis clotting drug begins

Disease control Recruiting now

This is an early-stage study to check the safety of a new drug called BAY 3389934 in healthy Japanese volunteers. The drug is being developed to treat a dangerous blood clotting problem that can happen during severe infections (sepsis). Researchers will give the drug at different…

Matched conditions: SEPSIS ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)

Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

SEPSIS ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)

Get alerted when new SEPSIS ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION (DIC) trials appear

First human test for new sepsis clotting drug begins